CELH
Celsius Holdings, Inc.
CELH has the edge over TR overall, supported by stronger modeled upside and stronger fundamentals.
TR
Tootsie Roll Industries, Inc.
TR trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
TR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
TR's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over TR in the historical PE scenario, which offers more potential upside but is not a forecast.
TR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $28.16 | -26% |
| Fair | 32x | $35.71 | -6.1% |
| Current | 34x | $38.02 | — |
| Expensive | 37x | $40.70 | +7.1% |
Historical ranges are pointers, not guarantees.
TR's PE is in its fair range at 34x.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
TR Forward outlook
There aren't enough analyst estimates for TR to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
TR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.11 | -11% |
| Q2 2026 | $1.28 | +5.8% |
| Q1 2026 | $1.33 | +13% |
| Q4 2025 | $1.33 | +16% |
| Q3 2025 | $1.25 | +1.6% |
| Q2 2025 | $1.21 | -3.2% |
| Q1 2025 | $1.18 | -4.1% |
| Q4 2024 | $1.15 | -4.2% |
TR has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over TR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over TR on profitability, with a higher operating margin.
TR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $229.1M | -1.6% |
| Q2 2026 | $154.2M | -0.6% |
| Q1 2026 | $151.5M | +2.1% |
| Q4 2025 | $196.3M | +1.5% |
| Q3 2025 | $232.7M | +3% |
| Q2 2025 | $155.1M | +2.9% |
| Q1 2025 | $148.5M | -3.1% |
| Q4 2024 | $193.4M | -2% |
TR's revenue grew through 2022 and has held roughly level since: $229M last quarter, down 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -3.1 points |
| Q2 2026 | -1.1% | -8.9 points |
| Q1 2026 | 15% | -0.2 points |
| Q4 2025 | 17% | -3 points |
| Q3 2025 | 14% | -1.7 points |
| Q2 2025 | 7.8% | -2.4 points |
| Q1 2025 | 16% | +8.3 points |
| Q4 2024 | 20% | +5.6 points |
TR's operating margin was 11% last quarter, down 3.1 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over TR on cash flow, with more consistent year-over-year improvement.
TR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $24.3M | -52% |
| Q2 2026 | -$34.8M | -$18.7M |
| Q1 2026 | $3.3M | +339% |
| Q4 2025 | $61M | -5.8% |
| Q3 2025 | $50.7M | -9.2% |
| Q2 2025 | -$16M | +$503K |
| Q1 2025 | $750K | -96% |
| Q4 2024 | $64.7M | +36% |
TR still generates free cash flow, though less than at its 2024 peak: $54M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over TR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
TR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -229K shares |
| 1 year | -0.3% | -259K shares |
| 3 years | -1.7% | -1.3M shares |
| 5 years | -4% | -3.1M shares |
| Available history | -7.1% | -5.7M shares |
TR has 75M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $13.7M |
| Q4 2025 | $1,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $6.5M |
| Q4 2024 | $11.3M |
| Q4 2023 | $5.6M |
| Q3 2023 | $11M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
TR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
TR has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
TR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.4 | Neutral |
| Stochastic | 49.8 | Neutral |
TR's weekly RSI is 48 (neutral) and its Stochastic is 50 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
TR PE vs Consumer Defensive Sector
| Metric | TR | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 19x | 75% above |
| PE % | 64 | 18 | 46 pts above |
TR has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
TR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.6 | 1.3% above |
| 20 week MA | $38.7 | 1.6% below |
| 50 week MA | $39.2 | 3.1% below |
| 100 week MA | $36.1 | 5.2% above |
| 200 week MA | $33.3 | 14% above |
TR has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
TR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.4 | $24.7 | -9.8% |
| 2021 | $24.7 | $31.3 | +27% |
| 2022 | $31.3 | $37.5 | +20% |
| 2023 | $37.5 | $29.5 | -21% |
| 2024 | $29.5 | $29.7 | +0.5% |
| 2025 | $29.7 | $37.5 | +26% |
| 2026 YTD | $37.5 | $38.0 | +1.5% |
TR has the edge over CELH on returns for 2026, with the stronger performance.